The research is a transformative step toward understanding the condition's genetic underpinnings and potential for ...

Deep brain stimulation is a treatment option for people with obsessive-compulsive disorder (OCD) when first-line treatments have not worked.

When focused on OCD-specific trials, glutamatergic medications are associated with significantly decreased scores on the Yale-Brown Obsessive Compulsive Scale.

For 23 trials that were OCD-specific, the mean reduction in scores on the 40-point Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was significant (mean difference -4.17 points, 95% CI -5.82 to -2. ...

For Millennials and Gen Z, "OCD" might seem like a trendy buzzword for an obsession with cleanliness. But hold on—there's so much more to it than meets the eye.

The most widely accepted tool for OCD screening is the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), which rates the severity of symptoms on a scale from 0 to 4, evaluating factors, such as: ...

The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) is one of the most common tools for evaluating OCD.

ABSTRACT: Background: There is limited knowledge about obsessive-compulsive disorder (OCD) in people with intellectual disabilities (IDs). This paper describes the manifestation of compulsive ...

Using the Yale-Brown Obsessive-Compulsive Scale, the patient’s obsessive-compulsive score reduced from 32 to 20 pre- and post-implant, a 37.5% reduction from baseline.

A screening period introduced the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), which rated severity of OCD symptoms in participants ahead of the initial study phase with participants randomized ...

In a recent study published in the Journal of Neurology, Neurosurgery & Psychiatry, researchers investigated the effectiveness of deep brain stimulation (DBS) against treatment-resistant obsessive ...